Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

4TTM

Racemic structure of kalata B1 (kB1)

Summary for 4TTM
Entry DOI10.2210/pdb4ttm/pdb
DescriptorKalata-B1, D-kalata B1 (3 entities in total)
Functional Keywordscyclic peptide, disulfide bonds, plant protein
Biological sourceOldenlandia affinis
More
Total number of polymer chains2
Total formula weight5834.69
Authors
Wang, C.K.,King, G.J.,Craik, D.J. (deposition date: 2014-06-22, release date: 2014-09-10, Last modification date: 2024-11-06)
Primary citationWang, C.K.,King, G.J.,Northfield, S.E.,Ojeda, P.G.,Craik, D.J.
Racemic and Quasi-Racemic X-ray Structures of Cyclic Disulfide-Rich Peptide Drug Scaffolds.
Angew.Chem.Int.Ed.Engl., 53:11236-11241, 2014
Cited by
PubMed Abstract: Cyclic disulfide-rich peptides have exceptional stability and are promising frameworks for drug design. We were interested in obtaining X-ray structures of these peptides to assist in drug design applications, but disulfide-rich peptides can be notoriously difficult to crystallize. To overcome this limitation, we chemically synthesized the L- and D-forms of three prototypic cyclic disulfide-rich peptides: SFTI-1 (14-mer with one disulfide bond), cVc1.1 (22-mer with two disulfide bonds), and kB1 (29-mer with three disulfide bonds) for racemic crystallization studies. Facile crystal formation occurred from a racemic mixture of each peptide, giving structures solved at resolutions from 1.25 Å to 1.9 Å. Additionally, we obtained the quasi-racemic structures of two mutants of kB1, [G6A]kB1, and [V25A]kB1, which were solved at a resolution of 1.25 Å and 2.3 Å, respectively. The racemic crystallography approach appears to have broad utility in the structural biology of cyclic peptides.
PubMed: 25168664
DOI: 10.1002/anie.201406563
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9001 Å)
Structure validation

227111

數據於2024-11-06公開中

PDB statisticsPDBj update infoContact PDBjnumon